BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251113
DTEND;VALUE=DATE:20251115
DTSTAMP:20250215T051822Z
CREATED:20250215T051803Z
LAST-MODIFIED:20250215T051822Z
UID:7226-1762992000-1763164799@thebiocalendar.com
SUMMARY:5th Investigator-Initiated Trials Summit
DESCRIPTION:As investigator-initiated trials grow more intricate\, your team needs the most up-to-date strategies on building successful IITs\, forecasting budgets\, achieving study milestones\, and brainstorming innovative KPI strategies. Save the date for November 13-14 for DGE’s 5th Investigator Initiated Trials conference! Back by popular demand\, our all-new agenda provides answers to your most urgent questions about the best practices for reviewing\, selecting\, and funding research investigators! \nThis conference had so many great takeaways. All the speakers’ candor and transparency really helped to move the field and agenda forward. I learned so much about how industry views and conducts IITs.” – Thomas Jefferson University \n“Attending the 4th Investigator Initiated Trials Summit presents an invaluable opportunity to gain insights into IIT programs across academia\, healthcare\, and industry. The summit facilitates networking with peers\, fostering the exchange of experiences\, challenges\, and best practices within the Investigator Initiated Research landscape.” – Hackensack Meridian Health
URL:https://thebiocalendar.com/event/5th-investigator-initiated-trials-summit/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/02/5th-Investigator-Initiated-Trials-Summit.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251113T080000
DTEND;TZID=America/Los_Angeles:20251113T120000
DTSTAMP:20251029T225251Z
CREATED:20251029T225142Z
LAST-MODIFIED:20251029T225251Z
UID:9425-1763020800-1763035200@thebiocalendar.com
SUMMARY:Gray\, Gray & Gray Year End Planning Seminar - Straight Talk on Taxes\, Tariffs & Trends
DESCRIPTION:2025 Year End Planning Seminar Registration\n\n\n\n\n\n\n\n\n\n\n\nRegister now for Gray\, Gray & Gray’s Year End Planning Seminar on Thursday\, November 13th! \nIn-Person: Gray\, Gray & Gray’s Canton Office\n150 Royall Street\nCanton\, MA 02021 \n  \nRegistration\, Breakfast & Networking: 8:00 am – 9:00 am\nSeminar Sessions: 9:00 am – 12:00 pm
URL:https://thebiocalendar.com/event/gray-gray-gray-year-end-planning-seminar-straight-talk-on-taxes-tariffs-trends/
LOCATION:Canton\, Canton\, MA\, 02021\, United States
CATEGORIES:Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251113T090000
DTEND;TZID=America/Los_Angeles:20251113T120000
DTSTAMP:20251008T125302Z
CREATED:20251008T125302Z
LAST-MODIFIED:20251008T125302Z
UID:9252-1763024400-1763035200@thebiocalendar.com
SUMMARY:Regional Biotechnology Conference
DESCRIPTION:The Regional Biotechnology Conference is an annual conference that attracts more than 100 of the region’s movers and shakers for a half-day of dynamic speakers and topics that are important to start-up and early stage biotech company leaders. This year’s conference will feature keynote speakers\, Nicholas A. Siciliano\, Ph.D.\, CEO of Vittoria Biotherapeutics. The afternoon will include a Health Equity panel of experts!
URL:https://thebiocalendar.com/event/regional-biotechnology-conference-3/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/10/2025-RBC-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251113T110000
DTEND;TZID=America/New_York:20251113T120000
DTSTAMP:20251023T135638Z
CREATED:20251023T135638Z
LAST-MODIFIED:20251023T135638Z
UID:9375-1763031600-1763035200@thebiocalendar.com
SUMMARY:Viability On The Line: Defining Minimum Quality For CGT Raw Materials
DESCRIPTION:The minimum-viable-product concept was born not in advanced therapy\, but in the tech sector. It asks: What’s the smallest set of materials or features required to achieve the desired outcome? This principle can be a powerful guide when sourcing raw materials for gene therapy.  \nExecutive Editor Jon O’Connell hosts this Cell & Gene Live event\, exploring whether minimum viability can help gene therapy developers make smarter sourcing decisions — from research-grade production through clinical and commercial phases\, where cost and quality can make or break a product. \nExperts Yan Zhi\, Ph.D.\, a director and product manager at CSL Behring\, and Lawrence Thompson\, Ph.D.\, an associate research fellow at Pfizer\, will talk about sourcing and outsourcing decisions in the context of product quality\, risk\, and financial strategy. This is more than phase-appropriate supply chain strategies. Join us for an interactive discussion to unpack viability at the individual raw material level and the product candidate level.
URL:https://thebiocalendar.com/event/viability-on-the-line-defining-minimum-quality-for-cgt-raw-materials/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/10/11-13-25-CGL-HTML-600x300-1.png
END:VEVENT
END:VCALENDAR